HomeRVPH • NASDAQ
add
Reviva Pharmaceuticals Holdings, Inc.
Previous close
$2.98
Day range
$2.94 - $3.08
Year range
$2.67 - $9.25
Market cap
83.48M USD
Avg Volume
296.46K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.99M | -14.60% |
Net income | -9.72M | 19.24% |
Net profit margin | — | — |
Earnings per share | -0.35 | 7.89% |
EBITDA | — | — |
Effective tax rate | 0.05% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 23.37M | 26.18% |
Total assets | 23.70M | 25.24% |
Total liabilities | 17.98M | 70.78% |
Total equity | 5.72M | — |
Shares outstanding | 27.92M | — |
Price to book | 14.90 | — |
Return on assets | -171.70% | — |
Return on capital | 1,937.09% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -9.72M | 19.24% |
Cash from operations | -8.88M | -89.24% |
Cash from investing | — | — |
Cash from financing | 27.27M | 146,813.77% |
Net change in cash | 18.40M | 493.73% |
Free cash flow | -1.41M | -233.12% |
About
Founded
2018
Headquarters
Website
Employees
15